A clinical trial to look at how safe RO6874281 is, either on its own or in combination with trastuzumab or cetuximab, in patients with different types of solid tumours (BP29842)

A Study Evaluating Safety, Pharmacokinetics, and Therapeutic Activity of RO6874281 as a Single Agent (Part A) or in Combination With Trastuzumab or Cetuximab (Part B or C)